Publication Information

{'id': 'https://openalex.org/W2963333658', 'doi': 'https://doi.org/10.1188/19.cjon.355-358', 'title': 'Neurologic Complications: Effects of Ipilimumab and Nivolumab Therapy in Patients With Metastatic Melanoma', 'display_name': 'Neurologic Complications: Effects of Ipilimumab and Nivolumab Therapy in Patients With Metastatic Melanoma', 'publication_year': 2019, 'publication_date': '2019-07-19', 'ids': {'openalex': 'https://openalex.org/W2963333658', 'doi': 'https://doi.org/10.1188/19.cjon.355-358', 'mag': '2963333658', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/31322610'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1188/19.cjon.355-358', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S203399934', 'display_name': 'Clinical journal of oncology nursing', 'issn_l': '1092-1095', 'issn': ['1092-1095', '1538-067X'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310315848', 'host_organization_name': 'Oncology Nursing Society', 'host_organization_lineage': ['https://openalex.org/P4310315848'], 'host_organization_lineage_names': ['Oncology Nursing Society'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5049335841', 'display_name': 'Jessica Latchman', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I3019308854', 'display_name': 'Moffitt Cancer Center', 'ror': 'https://ror.org/01xf75524', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I3019308854']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Jessica Latchman', 'raw_affiliation_strings': ['H. Lee Moffitt Cancer and Research Institute.'], 'affiliations': [{'raw_affiliation_string': 'H. Lee Moffitt Cancer and Research Institute.', 'institution_ids': ['https://openalex.org/I3019308854']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5077815328', 'display_name': 'Ann Guastella', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I3019308854', 'display_name': 'Moffitt Cancer Center', 'ror': 'https://ror.org/01xf75524', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I3019308854']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Ann Guastella', 'raw_affiliation_strings': ['H. Lee Moffitt Cancer and Research Institute.'], 'affiliations': [{'raw_affiliation_string': 'H. Lee Moffitt Cancer and Research Institute.', 'institution_ids': ['https://openalex.org/I3019308854']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5005573244', 'display_name': 'Cindy Tofthagen', 'orcid': 'https://orcid.org/0000-0002-3757-5823'}, 'institutions': [{'id': 'https://openalex.org/I4210146710', 'display_name': 'Mayo Clinic in Florida', 'ror': 'https://ror.org/03zzw1w08', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1330342723', 'https://openalex.org/I4210146710']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Cindy Tofthagen', 'raw_affiliation_strings': ['Mayo Clinic Florida.'], 'affiliations': [{'raw_affiliation_string': 'Mayo Clinic Florida.', 'institution_ids': ['https://openalex.org/I4210146710']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 2, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.117, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 2, 'citation_normalized_percentile': {'value': 0.605942, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 69, 'max': 74}, 'biblio': {'volume': '23', 'issue': '4', 'first_page': '355', 'last_page': '358'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10158', 'display_name': 'Cancer Immunotherapy and Biomarkers', 'score': 0.9991, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10158', 'display_name': 'Cancer Immunotherapy and Biomarkers', 'score': 0.9991, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11491', 'display_name': 'CAR-T cell therapy research', 'score': 0.9984, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11533', 'display_name': 'Melanoma and MAPK Pathways', 'score': 0.9983, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [], 'concepts': [{'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.9724051}, {'id': 'https://openalex.org/C2780030458', 'wikidata': 'https://www.wikidata.org/wiki/Q7041828', 'display_name': 'Nivolumab', 'level': 4, 'score': 0.95654094}, {'id': 'https://openalex.org/C2781433595', 'wikidata': 'https://www.wikidata.org/wiki/Q2459042', 'display_name': 'Ipilimumab', 'level': 4, 'score': 0.95443535}, {'id': 'https://openalex.org/C2777658100', 'wikidata': 'https://www.wikidata.org/wiki/Q180614', 'display_name': 'Melanoma', 'level': 2, 'score': 0.8701147}, {'id': 'https://openalex.org/C2994587330', 'wikidata': 'https://www.wikidata.org/wiki/Q180614', 'display_name': 'Metastatic melanoma', 'level': 3, 'score': 0.7712501}, {'id': 'https://openalex.org/C2777701055', 'wikidata': 'https://www.wikidata.org/wiki/Q1427096', 'display_name': 'Immunotherapy', 'level': 3, 'score': 0.5841718}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.57547826}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.5664448}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.55623454}, {'id': 'https://openalex.org/C16005928', 'wikidata': 'https://www.wikidata.org/wiki/Q171171', 'display_name': 'Dermatology', 'level': 1, 'score': 0.43496}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.15619487}], 'mesh': [{'descriptor_ui': 'D000074322', 'descriptor_name': 'Antineoplastic Agents, Immunological', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': True}, {'descriptor_ui': 'D000074324', 'descriptor_name': 'Ipilimumab', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': True}, {'descriptor_ui': 'D008545', 'descriptor_name': 'Melanoma', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D009362', 'descriptor_name': 'Neoplasm Metastasis', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': True}, {'descriptor_ui': 'D009420', 'descriptor_name': 'Nervous System', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': True}, {'descriptor_ui': 'D000077594', 'descriptor_name': 'Nivolumab', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': True}, {'descriptor_ui': 'D000074322', 'descriptor_name': 'Antineoplastic Agents, Immunological', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000074324', 'descriptor_name': 'Ipilimumab', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008545', 'descriptor_name': 'Melanoma', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008545', 'descriptor_name': 'Melanoma', 'qualifier_ui': 'Q000473', 'qualifier_name': 'pathology', 'is_major_topic': False}, {'descriptor_ui': 'D009420', 'descriptor_name': 'Nervous System', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000077594', 'descriptor_name': 'Nivolumab', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1188/19.cjon.355-358', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S203399934', 'display_name': 'Clinical journal of oncology nursing', 'issn_l': '1092-1095', 'issn': ['1092-1095', '1538-067X'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310315848', 'host_organization_name': 'Oncology Nursing Society', 'host_organization_lineage': ['https://openalex.org/P4310315848'], 'host_organization_lineage_names': ['Oncology Nursing Society'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/31322610', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'score': 0.86, 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 17, 'referenced_works': ['https://openalex.org/W1979895328', 'https://openalex.org/W216902937', 'https://openalex.org/W2265953833', 'https://openalex.org/W2320537501', 'https://openalex.org/W2470761206', 'https://openalex.org/W2521728442', 'https://openalex.org/W2532352313', 'https://openalex.org/W2569775853', 'https://openalex.org/W2571474733', 'https://openalex.org/W2589016133', 'https://openalex.org/W2603361374', 'https://openalex.org/W2606461710', 'https://openalex.org/W2607301376', 'https://openalex.org/W2736166064', 'https://openalex.org/W2789807515', 'https://openalex.org/W2890965651', 'https://openalex.org/W2896600825'], 'related_works': ['https://openalex.org/W4362552730', 'https://openalex.org/W4313890856', 'https://openalex.org/W4303981446', 'https://openalex.org/W4236421112', 'https://openalex.org/W3210130056', 'https://openalex.org/W3011204104', 'https://openalex.org/W2963333658', 'https://openalex.org/W2888298425', 'https://openalex.org/W2766929851', 'https://openalex.org/W2338693579'], 'abstract_inverted_index': {'Checkpoint': [0], 'inhibitors': [1], 'are': [2, 42, 79], 'a': [3], 'form': [4], 'of': [5, 30, 53, 63, 76], 'immunotherapy': [6], 'that': [7], 'have': [8], 'revolutionized': [9], 'treatment': [10, 48, 75], 'for': [11, 72], 'malignant': [12], 'melanoma,': [13], 'resulting': [14], 'in': [15], 'longer': [16], 'survival': [17], 'and': [18, 47, 65, 74], 'better': [19], 'disease': [20], 'control.': [21], 'Multiple': [22], 'autoimmune': [23], 'disorders': [24], 'can': [25], 'occur': [26], 'with': [27], 'the': [28], 'use': [29], 'checkpoint': [31], 'inhibitors,': [32], 'including': [33], 'severe,': [34], 'potentially': [35], 'fatal': [36], 'neurologic': [37, 40, 61, 77], 'complications.': [38], 'Although': [39], 'complications': [41, 62, 78], 'uncommon,': [43], 'their': [44], 'early': [45], 'recognition': [46], 'is': [49, 56], 'required.': [50], 'The': [51], 'purpose': [52], 'this': [54], 'article': [55], 'to': [57, 67], 'present': [58], 'information': [59], 'on': [60], 'ipilimumab': [64], 'nivolumab': [66], 'inform': [68], 'nursing': [69], 'practice.': [70], 'Recommendations': [71], 'evaluation': [73], 'reviewed.': [80]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2963333658', 'counts_by_year': [{'year': 2024, 'cited_by_count': 1}, {'year': 2021, 'cited_by_count': 1}], 'updated_date': '2024-12-15T15:22:00.108069', 'created_date': '2019-07-30'}